1 – 10 of 24
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Serum ARGS-aggrecan in a phase 2 clinical trial targeting osteoarthritis
(
- Contribution to journal › Article
- 2022
-
Mark
Safety, Pharmacokinetics, and Pharmacodynamics of the ADAMTS-5 Inhibitor GLPG1972/S201086 in Healthy Volunteers and Participants With Osteoarthritis of the Knee or Hip
(
- Contribution to journal › Article
-
Mark
Biological variation of human aggrecan ARGS neoepitope in synovial fluid and serum in early-stage knee osteoarthritis and after knee injury
(
- Contribution to journal › Article
-
Mark
Technical performance of a proximity extension assay inflammation biomarker panel with synovial fluid
(
- Contribution to journal › Article
- 2020
-
Mark
Molecular and imaging biomarkers of local inflammation at 2 years after anterior cruciate ligament injury do not associate with patient reported outcomes at 5 years
(
- Contribution to journal › Article
-
Mark
Higher aggrecan 1-F21 epitope concentration in synovial fluid early after anterior cruciate ligament injury is associated with worse knee cartilage quality assessed by gadolinium enhanced magnetic resonance imaging 20 years later
(
- Contribution to journal › Article
- 2019
-
Mark
Molecular and Structural Biomarkers of Inflammation at Two Years After Acute Anterior Cruciate Ligament Injury Do Not Predict Structural Knee Osteoarthritis at Five Years
(
- Contribution to journal › Article
-
Mark
Reply to letter by Deng et al. "Could the levels of inflammation biomarkers predict OA? : Comment on the article by Roemer FW et al."
(
- Contribution to journal › Letter
- 2018
-
Mark
α1-microglobulin protects against bleeding-induced oxidative damage in knee arthropathies
(
- Contribution to journal › Article
- 2017
-
Mark
Surgical reconstruction of ruptured anterior cruciate ligament prolongs trauma-induced increase of inflammatory cytokines in synovial fluid : An exploratory analysis in the KANON trial
(
- Contribution to journal › Article